[HTML][HTML] High-efficacy therapies for treatment-naïve individuals with relapsing–remitting multiple sclerosis
L Freeman, EE Longbrake, PK Coyle, B Hendin… - CNS drugs, 2022 - Springer
There are> 18 distinct disease-modifying therapy (DMT) options covering 10 mechanisms of
action currently approved by the US Food and Drug Administration for the treatment of …
action currently approved by the US Food and Drug Administration for the treatment of …
High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing-Remitting Multiple Sclerosis
L Freeman, EE Longbrake, PK Coyle, B Hendin… - CNS …, 2022 - search.proquest.com
There are> 18 distinct disease-modifying therapy (DMT) options covering 10 mechanisms of
action currently approved by the US Food and Drug Administration for the treatment of …
action currently approved by the US Food and Drug Administration for the treatment of …
High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis.
L Freeman, EE Longbrake, PK Coyle, B Hendin… - CNS …, 2022 - search.ebscohost.com
There are > 18 distinct disease-modifying therapy (DMT) options covering 10
mechanisms of action currently approved by the US Food and Drug Administration for the …
mechanisms of action currently approved by the US Food and Drug Administration for the …
[HTML][HTML] High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis
L Freeman, EE Longbrake, PK Coyle, B Hendin… - CNS Drugs, 2022 - ncbi.nlm.nih.gov
There are> 18 distinct disease-modifying therapy (DMT) options covering 10 mechanisms of
action currently approved by the US Food and Drug Administration for the treatment of …
action currently approved by the US Food and Drug Administration for the treatment of …
High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing-Remitting Multiple Sclerosis.
L Freeman, EE Longbrake, PK Coyle, B Hendin… - CNS Drugs, 2022 - europepmc.org
There are> 18 distinct disease-modifying therapy (DMT) options covering 10 mechanisms of
action currently approved by the US Food and Drug Administration for the treatment of …
action currently approved by the US Food and Drug Administration for the treatment of …
High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing-Remitting Multiple Sclerosis
L Freeman, EE Longbrake, PK Coyle… - CNS …, 2022 - pubmed.ncbi.nlm.nih.gov
There are> 18 distinct disease-modifying therapy (DMT) options covering 10 mechanisms of
action currently approved by the US Food and Drug Administration for the treatment of …
action currently approved by the US Food and Drug Administration for the treatment of …
[PDF][PDF] High‑Efficacy Therapies for Treatment‑Naïve Individuals with Relapsing–Remitting Multiple Sclerosis
L Freeman, EE Longbrake, PK Coyle, B Hendin… - CNS Drugs, 2022 - d-nb.info
There are> 18 distinct disease-modifying therapy (DMT) options covering 10 mechanisms of
action currently approved by the US Food and Drug Administration for the treatment of …
action currently approved by the US Food and Drug Administration for the treatment of …